Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: European Region
  • Asset Class: Equity
  • Geographic Focus: European Region

Aberdeen Global - European Equity NEW

+ Add to Watchlist

ABEEMIA:LX

1,367.75 EUR 21.22 1.53%

As of 00:59:30 ET on 03/26/2015.

Snapshot for Aberdeen Global - European Equity NEW (ABEEMIA)

Year To Date: +18.19% 3-Month: +17.95% 3-Year: +15.31% 52-Week Range: 1,075.56 - 1,400.04
1-Month: +3.93% 1-Year: +23.31% 5-Year: - Beta vs FTAW11: 0.80

Mutual Fund Chart for ABEEMIA

No chart data available.
  • ABEEMIA:LX 1,367.75
  • 1M
  • 1Y
Interactive ABEEMIA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ABEEMIA

Aberdeen Global - European Equity Fund is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is long-term total return. The Fund invests in equities and equity-related securities of companies with their registered office in Europe, and/or of companies which have the preponderance of their business activites in Europe.

Inception Date: 01-29-1993 Telephone: Tel: +352 46 40 10 820
Managers: JEREMY WHITLEY
Web Site: www.aberdeen-asset.com

Fundamentals for ABEEMIA

NAV (on 2015-03-26) 1,367.75
Assets (M) (on 2015-02-27) 337.33
Fund Leveraged N
Minimum Investment 1,000,000.00
Minimum Subsequent Investment 10,000.00

Dividends for ABEEMIA

No dividends reported

Fees & Expenses for ABEEMIA

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for ABEEMIA

Filing Date: 02/28/2015
Name Position Value % of Total
Roche Holding AG 57,000 13,873,079 4.096%
Rolls-Royce Holdings PLC 1,061,000 13,872,917 4.096%
Prudential PLC 608,000 13,650,361 4.030%
Nestle SA 183,000 12,804,357 3.781%
Novo Nordisk A/S 295,000 12,638,466 3.732%
Nordea Bank AB 1,026,000 12,337,861 3.643%
Schindler Holding AG 80,000 11,834,569 3.494%
Linde AG 65,000 11,817,000 3.489%
Schneider Electric SE 161,000 11,588,780 3.422%
British American Tobacco PLC 217,000 11,307,522 3.339%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil